Baxter International

Baxter International Inc.

Company type	Public
Traded as	NYSE: BAX S&P 500 component
Industry	Medical equipment
Founded	1931; 93 years ago (1931)
Founder	Donald Baxter
Headquarters	Deerfield, Illinois, U.S.
Key people	José E. Almeida (chairman & CEO) Jay Saccaro (CFO)
Products	Medical supplies to treat haemophilia and kidney disease and provide intravenous therapy
Revenue	US$14.81 billion (2023)
Operating income	US$380 million (2023)
Net income	US$2.663 billion (2023)
Total assets	US$28.28 billion (2023)
Total equity	US$8.468 billion (2023)
Number of employees	c. 60,000 (2023)
Website	baxter.com
Footnotes / references [1]

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.^[2]

The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.^[3]